Evidence map›Paper›PMID 37167459›Full record

ArticleBiomedica : revista del Instituto Nacional de Salud2023

Histopathology of COVID-19: An illustration of the findings from fatal cases.

Jorge Rivera, Sheryll Corchuelo, Julián Naizaque, Édgar Parra, Eugenio Aladino Meek, Diego Álvarez-Díaz, María Mercado, Orlando Torres-Fernández

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Biomedica : revista del Instituto Nacional de Salud, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Jorge RiveraGrupo de Morfología Celular, Dirección de Investigación en Salud Pública, Instituto Nacional de Salud, Bogotá, D.C., Colombia. jriverari7@yahoo.com.
Sheryll CorchueloGrupo de Morfología Celular, Dirección de Investigación en Salud Pública, Instituto Nacional de Salud, Bogotá, D.C., Colombia. scorchuelo@ins.gov.co.
Julián NaizaqueGrupo de Morfología Celular, Dirección de Investigación en Salud Pública, Instituto Nacional de Salud, Bogotá, D.C., Colombia. jnaizaque@ins.gov.co.
Édgar ParraGrupo de Patología, Dirección de Redes en Salud Pública, Instituto Nacional de Salud, Bogotá, D.C., Colombia. eparra@ins.gov.co.
Eugenio Aladino MeekGrupo de Patología, Dirección de Redes en Salud Pública, Instituto Nacional de Salud, Bogotá, D.C., Colombia. emeek@ins.gov.co.
Diego Álvarez-DíazGenómica de Microorganismos Emergentes, Dirección de Investigación en Salud Pública, Instituto Nacional de Salud, Bogotá, D.C., Colombia. dalvarezd@ins.gov.co.
María MercadoDirección de Investigación en Salud Pública, Instituto Nacional de Salud, Bogotá, D.C., Colombia. mmercado@ins.gov.co.
Orlando Torres-FernándezGrupo de Morfología Celular, Dirección de Investigación en Salud Pública, Instituto Nacional de Salud, Bogotá, D.C., Colombia. otorresf@ins.gov.co.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

COVID-19HumansSARS-CoV-2covid-19histopathology

Identifiers

PMID37167459
PMCPMC10481905

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.